Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q3 2014 (← Previous) (Next →)

Filing Date: Nov 14, 2014

Total Value: $184M (100.0% shares, 0.0% debt)

Holdings (70)

— BRISTOL MYERS SQUIBB CO 5.6%
Value $10.24M Shares 200,000 Share Price $51.18 Est. Cost/Share — Unrealized @ Report Date —
— VALEANT PHARMACEUTICALS INTL 3.6%
Value $6.56M Shares 50,000 Share Price $131.20 Est. Cost/Share — Unrealized @ Report Date —
— ABBVIE INC 3.1%
Value $5.776M Shares 100,000 Share Price $57.76 Est. Cost/Share — Unrealized @ Report Date —
— AGILENT TECHNOLOGIES INC 3.1%
Value $5.698M Shares 100,000 Share Price $56.98 Est. Cost/Share — Unrealized @ Report Date —
CYH COMMUNITY HEALTH SYS INC NEW 3.0%
Value $5.479M Shares 100,000 Share Price $54.79 * Est. Cost/Share $34.00 Unrealized @ Report Date +22.2%
— HORIZON PHARMA PLC 2.8%
Value $5.219M Shares 425,000 Share Price $12.28 Est. Cost/Share $12.28 Unrealized @ Report Date —
ZBH ZIMMER HLDGS INC 2.7%
Value $5.028M Shares 50,000 Share Price $100.56 * Est. Cost/Share $89.58 Unrealized @ Report Date 0.0%
— TORNIER N V 2.6%
Value $4.78M Shares 200,000 Share Price $23.90 Est. Cost/Share $21.17 Unrealized @ Report Date —
VRTX VERTEX PHARMACEUTICALS INC 2.4%
Value $4.492M Shares 40,000 Share Price $112.30 * Est. Cost/Share $95.21 Unrealized @ Report Date 0.0%
— ALLERGAN INC 2.4%
Value $4.455M Shares 25,000 Share Price $178.20 Est. Cost/Share $178.20 Unrealized @ Report Date —
— CEPHEID 2.4%
Value $4.403M Shares 100,000 Share Price $44.03 Est. Cost/Share — Unrealized @ Report Date —
HCA HCA HOLDINGS INC 2.3%
Value $4.231M Shares 60,000 Share Price $70.52 * Est. Cost/Share $52.14 Unrealized @ Report Date +17.8%
— MALLINCKRODT PUB LTD CO 2.2%
Value $4.057M Shares 45,000 Share Price $90.16 Est. Cost/Share $90.16 Unrealized @ Report Date —
— ZELTIQ AESTHETICS INC 2.1%
Value $3.96M Shares 175,000 Share Price $22.63 Est. Cost/Share $22.63 Unrealized @ Report Date —
ISRG INTUITIVE SURGICAL INC 2.1%
Value $3.925M Shares 8,500 Share Price $461.76 * Est. Cost/Share $49.65 Unrealized @ Report Date 0.0%
— CYBERONICS INC 2.1%
Value $3.837M Shares 75,000 Share Price $51.16 Est. Cost/Share $51.16 Unrealized @ Report Date —
— ARIAD PHARMACEUTICALS INC 2.1%
Value $3.78M Shares 700,000 Share Price $5.40 Est. Cost/Share $5.40 Unrealized @ Report Date —
— THORATEC CORP 2.0%
Value $3.742M Shares 140,000 Share Price $26.73 Est. Cost/Share $26.73 Unrealized @ Report Date —
ATRC ATRICURE INC 2.0%
Value $3.68M Shares 250,000 Share Price $14.72 * Est. Cost/Share $17.88 Unrealized @ Report Date -10.9%
— ACCURAY INC 2.0%
Value $3.63M Shares 500,000 Share Price $7.26 Est. Cost/Share $7.26 Unrealized @ Report Date —
— ACTAVIS PLC 2.0%
Value $3.619M Shares 15,000 Share Price $241.27 Est. Cost/Share $223.07 Unrealized @ Report Date —
— CONCERT PHARMACEUTICALS INC 1.9%
Value $3.543M Shares 280,966 Share Price $12.61 Est. Cost/Share $12.61 Unrealized @ Report Date —
— THERAPEUTICSMD INC 1.9%
Value $3.48M Shares 750,000 Share Price $4.64 Est. Cost/Share $5.07 Unrealized @ Report Date —
— ENVISION HEALTHCARE HLDGS IN 1.9%
Value $3.468M Shares 100,000 Share Price $34.68 Est. Cost/Share $34.68 Unrealized @ Report Date —
— ZS PHARMA INC 1.8%
Value $3.335M Shares 85,000 Share Price $39.24 Est. Cost/Share $39.24 Unrealized @ Report Date —
— VALEANT PHARMACEUTICALS INTL 1.8%
Value $3.28M Shares 25,000 Share Price $131.20 Est. Cost/Share $131.20 Unrealized @ Report Date —
— NEUROCRINE BIOSCIENCES INC 1.7%
Value $3.134M Shares 200,000 Share Price $15.67 Est. Cost/Share — Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 1.6%
Value $2.948M Shares 65,000 Share Price $45.35 Est. Cost/Share $45.35 Unrealized @ Report Date —
— PORTOLA PHARMACEUTICALS INC 1.6%
Value $2.907M Shares 115,000 Share Price $25.28 Est. Cost/Share $25.28 Unrealized @ Report Date —
— GW PHARMACEUTICALS PLC 1.5%
Value $2.83M Shares 35,000 Share Price $80.86 Est. Cost/Share $68.57 Unrealized @ Report Date —
ALNY ALNYLAM PHARMACEUTICALS INC 1.5%
Value $2.734M Shares 35,000 Share Price $78.11 * Est. Cost/Share $59.44 Unrealized @ Report Date +8.5%
— QUIDEL CORP 1.5%
Value $2.687M Shares 100,000 Share Price $26.87 Est. Cost/Share $26.87 Unrealized @ Report Date —
— SPECTRANETICS CORP 1.4%
Value $2.657M Shares 100,000 Share Price $26.57 Est. Cost/Share $23.62 Unrealized @ Report Date —
BRKR BRUKER CORP 1.4%
Value $2.592M Shares 140,000 Share Price $18.51 * Est. Cost/Share $19.52 Unrealized @ Report Date +5.1%
EW EDWARDS LIFESCIENCES CORP 1.4%
Value $2.554M Shares 25,000 Share Price $102.16 * Est. Cost/Share $12.39 Unrealized @ Report Date +27.4%
EXAS EXACT SCIENCES CORP 1.3%
Value $2.423M Shares 125,000 Share Price $19.38 * Est. Cost/Share $18.34 Unrealized @ Report Date 0.0%
— CHIMERIX INC 1.2%
Value $2.223M Shares 80,500 Share Price $27.61 Est. Cost/Share $27.61 Unrealized @ Report Date —
PTCT PTC THERAPEUTICS INC 1.2%
Value $2.201M Shares 50,000 Share Price $44.02 * Est. Cost/Share $31.28 Unrealized @ Report Date 0.0%
— ANTARES PHARMA INC 1.1%
Value $2.013M Shares 1,100,000 Share Price $1.83 Est. Cost/Share $1.83 Unrealized @ Report Date —
— AEGERION PHARMACEUTICALS INC 1.1%
Value $2.003M Shares 60,000 Share Price $33.38 Est. Cost/Share $33.38 Unrealized @ Report Date —
— MEDTRONIC INC 1.0%
Value $1.859M Shares 30,000 Share Price $61.97 Est. Cost/Share $63.76 Unrealized @ Report Date —
— DEPOMED INC 1.0%
Value $1.823M Shares 120,000 Share Price $15.19 Est. Cost/Share $12.77 Unrealized @ Report Date —
— TANDEM DIABETES CARE INC 1.0%
Value $1.765M Shares 131,500 Share Price $13.42 Est. Cost/Share $13.42 Unrealized @ Report Date —
— NUVASIVE INC 0.9%
Value $1.744M Shares 50,000 Share Price $34.88 Est. Cost/Share $34.88 Unrealized @ Report Date —
— AVALANCHE BIOTECHNOLOGIES IN 0.9%
Value $1.71M Shares 50,000 Share Price $34.20 Est. Cost/Share $34.20 Unrealized @ Report Date —
NBIX NEUROCRINE BIOSCIENCES INC 0.9%
Value $1.567M Shares 100,000 Share Price $15.67 * Est. Cost/Share $14.95 Unrealized @ Report Date 0.0%
— ACHILLION PHARMACEUTICALS IN 0.8%
Value $1.497M Shares 150,000 Share Price $9.98 Est. Cost/Share — Unrealized @ Report Date —
— ZAFGEN INC 0.8%
Value $1.474M Shares 75,000 Share Price $19.65 Est. Cost/Share $19.65 Unrealized @ Report Date —
ENTA ENANTA PHARMACEUTICALS INC 0.8%
Value $1.385M Shares 35,000 Share Price $39.57 Est. Cost/Share $36.87 Unrealized @ Report Date +8.1%
— ONCOTHYREON INC 0.7%
Value $1.344M Shares 700,000 Share Price $1.92 Est. Cost/Share $1.92 Unrealized @ Report Date —
SNN SMITH & NEPHEW PLC 0.7%
Value $1.263M Shares 15,000 Share Price $84.20 Est. Cost/Share $89.30 Unrealized @ Report Date —
— BLUEBIRD BIO INC 0.7%
Value $1.256M Shares 35,000 Share Price $35.89 Est. Cost/Share $35.89 Unrealized @ Report Date —
AGIO AGIOS PHARMACEUTICALS INC 0.7%
Value $1.227M Shares 20,000 Share Price $61.35 * Est. Cost/Share $43.10 Unrealized @ Report Date 0.0%
PBYI PUMA BIOTECHNOLOGY INC 0.6%
Value $1.193M Shares 5,000 Share Price $238.60 * Est. Cost/Share $176.01 Unrealized @ Report Date +16.7%
— ALIMERA SCIENCES INC 0.6%
Value $1.084M Shares 200,000 Share Price $5.42 Est. Cost/Share — Unrealized @ Report Date —
— VANDA PHARMACEUTICALS INC 0.6%
Value $1.038M Shares 100,000 Share Price $10.38 Est. Cost/Share — Unrealized @ Report Date —
— NANOSTRING TECHNOLOGIES INC 0.5%
Value $985K Shares 90,000 Share Price $10.94 Est. Cost/Share $18.50 Unrealized @ Report Date —
— ALCOBRA LTD 0.4%
Value $772K Shares 50,000 Share Price $15.44 Est. Cost/Share — Unrealized @ Report Date —
— RECEPTOS INC 0.4%
Value $764K Shares 12,300 Share Price $62.11 Est. Cost/Share $42.60 Unrealized @ Report Date —
— BIOLASE INC 0.4%
Value $747K Shares 300,000 Share Price $2.49 Est. Cost/Share $2.41 Unrealized @ Report Date —
— OCERA THERAPEUTICS INC 0.3%
Value $613K Shares 125,000 Share Price $4.90 Est. Cost/Share $10.04 Unrealized @ Report Date —
HRTX HERON THERAPEUTICS INC 0.3%
Value $583K Shares 70,000 Share Price $8.33 * Est. Cost/Share $11.95 Unrealized @ Report Date -22.0%
— LIPOCINE INC NEW 0.3%
Value $561K Shares 91,768 Share Price $6.11 Est. Cost/Share $6.11 Unrealized @ Report Date —
— ASSEMBLY BIOSCIENCES INC 0.3%
Value $532K Shares 65,000 Share Price $8.18 Est. Cost/Share $8.18 Unrealized @ Report Date —
— PSIVIDA CORP 0.2%
Value $442K Shares 100,000 Share Price $4.42 Est. Cost/Share $4.42 Unrealized @ Report Date —
— UNILIFE CORP NEW 0.2%
Value $344K Shares 150,000 Share Price $2.29 Est. Cost/Share $4.21 Unrealized @ Report Date —
— CATALYST PHARM PARTNERS INC 0.2%
Value $332K Shares 100,000 Share Price $3.32 Est. Cost/Share — Unrealized @ Report Date —
— WRIGHT MED GROUP INC 0.2%
Value $288K Shares 134,000 Share Price $2.15 Est. Cost/Share $1.40 Unrealized @ Report Date —
— FLEXION THERAPEUTICS INC 0.1%
Value $228K Shares 12,488 Share Price $18.26 Est. Cost/Share $18.26 Unrealized @ Report Date —
— AMARIN CORP PLC 0.1%
Value $218K Shares 200,000 Share Price $1.09 Est. Cost/Share $1.09 Unrealized @ Report Date —